# ctDNA-guided Adjuvant Chemotherapy in Liver Metastasis of Colorectal Cancer

> **NCT05815082** · PHASE3 · RECRUITING · sponsor: **Sixth Affiliated Hospital, Sun Yat-sen University** · enrollment: 490 (estimated)

## Conditions studied

- Colorectal Cancer
- Liver Metastases
- Circulating Tumor Cell
- Chemotherapy Effect

## Interventions

- **PROCEDURE:** Colorectal cancer resection combined with liver metastasis resection.
- **DRUG:** FOLFOX chemotherapy regimen

## Key facts

- **NCT ID:** NCT05815082
- **Lead sponsor:** Sixth Affiliated Hospital, Sun Yat-sen University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-02-20
- **Primary completion:** 2031-02-20
- **Final completion:** 2033-02-20
- **Target enrollment:** 490 (ESTIMATED)
- **Last updated:** 2023-04-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05815082

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05815082, "ctDNA-guided Adjuvant Chemotherapy in Liver Metastasis of Colorectal Cancer". Retrieved via AI Analytics 2026-06-22 from https://api.ai-analytics.org/clinical/NCT05815082. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*